首页 | 官方网站   微博 | 高级检索  
     

1982至2020年中国肾移植受者合并隐球菌病的系统分析
引用本文:王会伟,蔡良奇,李航,薛潇春,刘晓刚,陈青,陈晓燕,潘炜华,廖万清.1982至2020年中国肾移植受者合并隐球菌病的系统分析[J].菌物学报,2021,40(4):707-720.
作者姓名:王会伟  蔡良奇  李航  薛潇春  刘晓刚  陈青  陈晓燕  潘炜华  廖万清
作者单位:1.海军军医大学上海长征医院皮肤科 上海长征医院皮肤病与真菌病研究所 上海 2000032.厦门大学第一附属医院皮肤科 福建 厦门 3610033.延安大学医学院 陕西 延安 7160004.象山县第一人民医院皮肤性病科 浙江 宁波 315700
基金项目:国家传染病科技重大专项(2018ZX10101003);国家自然科学基金(31770161);中国工程院战略咨询课题(2019-XY-33);中国工程院战略咨询课题(19-HNXZ-06);中国工程院战略咨询课题(2020-XY-61-01)
摘    要:隐球菌病是威胁肾移植患者生命的严重感染性疾病,本文旨在报道我国肾移植患者合并隐球菌病(cryptococcosis in kidney transplant patients,C-KT)的情况。通过对208例患者的资料进行分析,发现隐球菌病平均发病时间为肾移植后(5.48±4.09)年,就诊时间为发病后(27.28±30.69)d,入院后确诊时间为(31.6±44.0)d。本研究中C-KT患者误诊率为23.1%,误诊患者占所有死亡患者的37.5%。此病可侵袭全身各个系统,最常见于中枢神经系统(脑)、呼吸系统(肺)和皮肤等。临床特征除发热、头痛、呕吐外,还常见为恶心、咳嗽、胸闷气短,结节、红斑、脓肿溃疡伴或不伴皮肤疼痛、触痛。诊断方法主要是墨汁染色、乳胶凝集素试验等,检出标本主要为脑脊液,血液,肺泡灌洗液,肺、皮肤病例活检组织等。首选治疗药物为两性霉素B脂质体、氟康唑、5-氟尿嘧啶和伏立康唑等,临床中有氟康唑耐药病例的报道。C-KT患者的总死亡率为15.8%。本文对全面了解肾移植患者合并隐球菌病的特征及对本病的诊断与治疗具有重要的意义。

关 键 词:肾移植  隐球菌病  新型隐球菌  
收稿时间:2020-11-26

Systematic analysis of secondary and complicated cryptococcosis in renal transplant recipients in China(1982-2020)
Authors:WANG Hui-Wei  CAI Liang-Qi  LI Hang  XUE Xiao-Chun  LIU Xiao-Gang  CHEN Qing  CHEN Xiao-Yan  PAN Wei-Hua  LIAO Wan-Qing
Affiliation:1. Department of Dermatology, the Second Affiliated Hospital of Naval Military Medical University, Shanghai 200003, China2. Department of Dermatology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian 361003, China3. Medical School of Yan’an University, Yan’an, Shaanxi 716000, China4. Xiangshan County First People’s Hospital, Ningbo, Zhejiang 315700, China
Abstract:Cryptococcosis is a serious infectious disease that threatens the lives of renal transplant patients. The purpose of this article is to report the situation of cryptococcosis in Chinese renal transplant patients (C-KT). Comprehensive analysis of the collected data of 208 patients indicates that the onset time of cryptococcosis is 5.48±4.09 years after kidney transplantation. There is an interval of 27.28±30.69 days before seeing a doctor after the occurrence of symptoms. The average diagnosis time is 31.6±44.0 days. The misdiagnosis rate of C-KT patients is 23.1%, accounting for 37.5% of all deaths. It can attack all systems of the body, most commonly in the central nervous system (brain), respiratory system (lung), skin, etc. In addition to fever, headache and vomiting, the common clinical features are nausea, cough, chest tightness and shortness of breath, nodular erythema, abscess and ulcer with or without skin pain and tenderness. The main diagnostic methods are Indian ink staining, latex agglutinin test, etc. The detected specimens are mainly cerebrospinal fluid, blood, alveolar lavage fluid, lung and skin case biopsy tissue, etc. The preferred therapeutic agents are amphotericin B liposome, fluconazole, 5-fluorouracil, voriconazole, etc. There are reports of fluconazole-resistant cases in the clinic. The overall mortality rate of C-KT patients is 15.8%. This article provides reference for comprehensive understanding of the characteristics of C-KT and the diagnosis and treatment of this disease.
Keywords:kidney transplantation  cryptococcosis  Cryptococcus neoformans  
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《菌物学报》浏览原始摘要信息
点击此处可从《菌物学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号